Fifth Lane Capital’s AMN Healthcare AMN Stock Holding History

Fifth Lane Capital’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,000	Closed	-$315K	–	61
2025 Q4	$315K	Buy	+20,000	New	+$357K	0.24%	69

Other funds holding AMN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fifth Lane Capital's AMN Position: Q1 2026 in Review

Fifth Lane Capital sold out of AMN Healthcare (AMN) in Q1 2026, closing a stake of 20,578 shares — an estimated $324K sold.

Fifth Lane Capital first reported a position in AMN in Q3 2025 and held it in 2 quarters. The position peaked at $324K in Q4 2025. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.

Fifth Lane Capital reported no remaining AMN Healthcare position as of Q1 2026 after selling out during the quarter.
Fifth Lane Capital sold 20,578 AMN Healthcare shares in Q1 2026, an estimated $324K.
Fifth Lane Capital first reported a position in AMN Healthcare in Q3 2025 and held it in 2 quarters.
Fifth Lane Capital's AMN Healthcare position peaked at $324K in Q4 2025.
249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.

Based on Fifth Lane Capital's 13F filing for Q1 2026, filed 15 May 2026.